Drug intelligence / Profile preview

Ying ti sheng gu fang

Development stage: Preclinical
Lead developer: Xi'an Honghui Hospital
Administration: Oral

Overview

Ying ti sheng gu fang is a Traditional Chinese Medicine (TCM) formula developed by the Red Union Hospital (Xi'an Honghui Hospital) affiliated to Xi'an Jiaotong University. It is primarily investigated for the treatment of musculoskeletal disorders, including sarcopenia and osteoporosis, particularly in patients with osteoporotic vertebral fractures. The formula is based on the TCM philosophy of 'internal and external treatment' and the 'equal treatment of muscles and bones,' aiming to strengthen both skeletal and muscular systems. In clinical research, it is often evaluated as part of a multi-modal intervention combining TCM with physical therapies such as whole-body vibration, electromagnetic field therapy, and Baduanjin exercise.

Other names: Yingtishenggu formulaYingtishenggu decoction

Beyond the preview

Go deeper on Ying ti sheng gu fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ying ti sheng gu fang.

Explore the full profile